2022/05/12 ALA-1000 Received notice of patent allowance from Director de Invenciones y Nuevas Tecnologías INDECOPI , Application No. 000487-2019/DIN.Post author:alarpharmPost published:13 . 5 . 2022Post category:Media releases You Might Also Like 2023/10/12 ALA-2000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 108147847) 29 . 2 . 2024 2023/10/12 ALA-2000 has received a notice of allowance from Russian Patent and Trademark Office (PUPTO) after examination. (Patent Application No. 2021114222) 29 . 2 . 2024 2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5) 10 . 8 . 2023 2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022 2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B 26 . 7 . 2023
2023/10/12 ALA-2000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 108147847) 29 . 2 . 2024
2023/10/12 ALA-2000 has received a notice of allowance from Russian Patent and Trademark Office (PUPTO) after examination. (Patent Application No. 2021114222) 29 . 2 . 2024
2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5) 10 . 8 . 2023
2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022
2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B 26 . 7 . 2023